103 related articles for article (PubMed ID: 11335961)
1. Changing clinical course of patients with malignant mesothelioma: implications for FNA cytology and utility of immunocytochemical staining.
Yu GH; Soma L; Hahn S; Friedberg JS
Diagn Cytopathol; 2001 May; 24(5):322-7. PubMed ID: 11335961
[TBL] [Abstract][Full Text] [Related]
2. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of malignant mesothelioma by fine needle aspiration of a cervical lymph node. A case report.
Ansari NA; Derias NW
Acta Cytol; 2000; 44(1):70-4. PubMed ID: 10667164
[TBL] [Abstract][Full Text] [Related]
4. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
5. Primary diagnosis of malignant mesothelioma by fine-needle aspiration of a supraclavicular lymph node.
Tafazzoli A; Raza A; Martin SE
Diagn Cytopathol; 2005 Aug; 33(2):122-5. PubMed ID: 16007670
[TBL] [Abstract][Full Text] [Related]
6. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
Hyun TS; Barnes M; Tabatabai ZL
Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers in fine-needle aspiration washout for cervical lymphadenopathy in patients with known malignancy: preliminary study.
Suh YJ; Kim MJ; Kim J; Yoon JH; Moon HJ; Kim EK
AJR Am J Roentgenol; 2011 Oct; 197(4):W730-6. PubMed ID: 21940546
[TBL] [Abstract][Full Text] [Related]
9. Occult metastatic mesothelioma--diagnosis by fine-needle aspiration. A case report.
Craig FE; Fishback NF; Schwartz JG; Powers CN
Am J Clin Pathol; 1992 Apr; 97(4):493-7. PubMed ID: 1553914
[TBL] [Abstract][Full Text] [Related]
10. A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
Hurtuk MG; Carbone M
Anticancer Res; 2004; 24(5B):3097-102. PubMed ID: 15510595
[TBL] [Abstract][Full Text] [Related]
11. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
12. Cytomorphology of metastatic mesothelioma in fine-needle aspiration specimens.
Yu GH; Baloch ZW; Gupta PK
Diagn Cytopathol; 1999 Jun; 20(6):328-32. PubMed ID: 10352904
[TBL] [Abstract][Full Text] [Related]
13. Malignant biphasic peritoneal mesothelioma in a child: fine-needle aspiration cytology, histopathology, and immunohistochemical features along with review of literature.
Arora SK; Srinivasan R; Nijhawan R; Bansal D; Menon P
Diagn Cytopathol; 2012 Dec; 40(12):1112-5. PubMed ID: 21574263
[TBL] [Abstract][Full Text] [Related]
14. Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration.
Cimbaluk D; Kasuganti D; Kluskens L; Reddy V; Gattuso P
Diagn Cytopathol; 2006 Jan; 34(1):33-6. PubMed ID: 16355399
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological characteristic of metastatic malignant mesothelioma initially diagnosed by lymph node biopsy.
Zhu XL; Gao LM; Li F; Liu WP; Zhang WY; Li GD; Zhang XH; Chen M; Liu XY; Zhao S
Pathol Res Pract; 2017 Jun; 213(6):598-605. PubMed ID: 28551387
[TBL] [Abstract][Full Text] [Related]
16. Fine needle aspiration cytology of malignant mesothelioma.
Sterrett GF; Whitaker D; Shilkin KB; Walters MN
Acta Cytol; 1987; 31(2):185-93. PubMed ID: 3469852
[TBL] [Abstract][Full Text] [Related]
17. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients.
Jhala NC; Jhala D; Eloubeidi MA; Chhieng DC; Crowe DR; Roberson J; Eltoum I
Cancer; 2004 Oct; 102(5):308-14. PubMed ID: 15376200
[TBL] [Abstract][Full Text] [Related]
20. Calretinin: a novel immunocytochemical marker for mesothelioma.
Doglioni C; Dei Tos AP; Laurino L; Iuzzolino P; Chiarelli C; Celio MR; Viale G
Am J Surg Pathol; 1996 Sep; 20(9):1037-46. PubMed ID: 8764740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
